Genetic Variants of Fibroblast Growth Factor Receptor 2 ( FGFR2 ) Are Associated with Breast Cancer Risk in Chinese Women of the Han Nationality

Fan Chen,Min Lv,Yun Xue,Jing Zhou,Feifei Hu,Xin Chen,Zhanqin Zhao,Yang Li,XingGuo Wang
DOI: https://doi.org/10.1007/s00251-011-0564-2
2012-01-01
Immunogenetics
Abstract:Fibroblast growth factor receptor 2 (FGFR2), a recently described risk factor for breast cancer, plays important roles in cell growth, invasiveness, motility, and angiogenesis. In attempt to investigate whether FGFR2 polymorphisms are associated with a risk of breast cancer in Chinese women of the Han nationality, we genotyped single-nucleotide polymorphisms (SNPs) of seven FGFR2 sites (rs2981582, rs17102287, rs17542768, rs10510097, rs11200012, rs3750817, rs2981578) in 816 women including 388 breast cancer patients and 428 healthy controls via the polymerase chain reaction single-strand conformation polymorphism procedure as well as sequence detection. Our results suggest that the A allele and AA genotype of SNP rs2981578 appear to be protective factors associated with breast cancer, while the CT genotype of SNP rs3750817 is a putative risk factor.
What problem does this paper attempt to address?